There are no articles in this category. If subcategories display on this page, they may have articles.

Subcategories

At GenoScreen, our genomics expertise is built on collaboration with a dense network of scientific, industrial and institutional partners. These partnerships strengthen our ability to innovate, co-develop new technologies and advance research in molecular microbiology.

A network of strategic partners

We actively collaborate with:

Research institutes, universities and hospitals

 

 

Competitive clusters specialized in biotechnology and healthcare

 

Public funding bodies

 

A co-development strategy

Our research projects are carried out with recognized partners in France and abroad. Together, we can :

  • Co-develop innovative genomics and bioinformatics solutions
  • Reply to national and international applications for projects (Horizon Europe, ANR, etc.)
  • Test and validate our technologies in a variety of environments
  • Launch the implementation of concrete solutions for health, agriculture and the environment

 

Why collaborate with GenoScreen?

  • Access to an innovative sequencing technology platform
  • Access to recognized expertise in bioinformatics analysis and biomarkers
  • Benefit from our ability to manage collaborative R&D projects
  • Strive for health, agriculture and environment  

 

Join our network of partners

Do you represent a company, laboratory or public body? Contact us to discuss a collaboration or partnership.

 

 

Frequently asked questions

What kind of partners work with GenoScreen?

GenoScreen works with academic laboratories, biotech companies and clusters.

What are the benefits of these partnerships?

They help us co-develop technologies, co-finance projects and accelerate innovation.

How can I propose a partnership?

You can contact us via our contact form to discuss your project and identify a potential collaboration.

GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.

Our projects are designed to:

  • Improve the diagnosis and management of acute/chronic diseases on humans and animals,
  • Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.

The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.

By continuing your visit to this site, you accept the use of statistics cookies